Pan Zhao
P.R. China
Shenzhen, China
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
SNHG17 Reprograms Energy Metabolism of Breast Cancer by Activating Mitochondrial DNA Transcription.
Journal: Cancer research
Published: April 19, 2024
ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells.
Journal: Nature communications
Published: October 02, 2023
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD).
Journal: Biomaterials research
Published: January 01, 2023
Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL.
Journal: Cancer medicine
Published: November 18, 2021
Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing.
Journal: Molecular cancer
Published: July 10, 2020
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications.
Journal: Signal transduction and targeted therapy
Published: June 16, 2020
Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders.
Journal: Nature communications
Published: May 31, 2020
Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells.
Journal: Stem cell research & therapy
Published: October 11, 2019
Knockdown of Thymidine Kinase 1 Suppresses Cell Proliferation, Invasion, Migration, and Epithelial-Mesenchymal Transition in Thyroid Carcinoma Cells.
Journal: Frontiers in oncology
Published: October 10, 2019
Promoter hypermethylation of the CFTR gene as a novel diagnostic and prognostic marker of breast cancer.
Journal: Cell biology international
Published: August 21, 2019
Last Updated: 09/26/2026